propiconazole has been researched along with Atrial Fibrillation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, DA; Lip, GY | 2 |
| Scott, M; Thomson, A | 1 |
3 other study(ies) available for propiconazole and Atrial Fibrillation
| Article | Year |
|---|---|
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
Topics: Anticoagulants; Atrial Fibrillation; Hemorrhage; Humans; Orbit; Risk Assessment; Risk Factors; Stroke | 2015 |
ACP Journal Club. The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Hemorrhage; Humans; Orbit; Stroke | 2016 |
Prompt recognition and treatment in traumatic retro-orbital hematoma in anticoagulated elderly people can save sight.
Topics: Accidental Falls; Acetazolamide; Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blindness; Combined Modality Therapy; Decompression, Surgical; Emergencies; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Orbit; Retrobulbar Hemorrhage; Tomography, X-Ray Computed; Visual Acuity; Warfarin; Wounds, Nonpenetrating | 2009 |